Affiliations 

  • 1 Department of Pharmacology, Faculty of Medicine, University of MalayaKuala Lumpur, Malaysia; Drug and Research Unit, Department of Pathology, Hospital Kuala LumpurKuala Lumpur, Malaysia
  • 2 Department of Pharmacology, Faculty of Medicine, University of Malaya Kuala Lumpur, Malaysia
  • 3 Department of Molecular Medicine, Faculty of Medicine, University of Malaya Kuala Lumpur, Malaysia
  • 4 Department of Chemistry, Faculty of Science, University of Malaya Kuala Lumpur, Malaysia
  • 5 Department of Molecular Medicine, Faculty of Medicine, University of MalayaKuala Lumpur, Malaysia; Faculty of Medicine, University of Malaya Centre for Proteomics Research, University of MalayaKuala Lumpur, Malaysia
  • 6 Department of Environmental and Industrial Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran, Iran
  • 7 Drug and Research Unit, Department of Pathology, Hospital Kuala Lumpur Kuala Lumpur, Malaysia
Front Pharmacol, 2015;6:313.
PMID: 26858642 DOI: 10.3389/fphar.2015.00313

Abstract

The aim of this study was to evaluate the cytotoxic potential of a novel nickel(II) complex (NTC) against WiDr and HT-29 human colon cancer cells by determining the IC50 using the standard MTT assay. The NTC displayed a strong suppressive effect on colon cancer cells with an IC50 value of 6.07 ± 0.22 μM and 6.26 ± 0.13 μM against WiDr and HT-29 respectively, after 24 h of treatment. Substantial reduction in the mitochondrial membrane potential and increase in the release of cytochrome c from the mitochondria directed the induction of the intrinsic apoptosis pathway by the NTC. Activation of this pathway was further evidenced by significant activation of caspase 3/7 and 9. The NTC was also shown to activate the extrinsic pathway of apoptosis via activation of caspase-8 which is linked to the suppression of NF-κB translocation to the nucleus. Cell cycle arrest in the G1 phase was confirmed by flow cytometry and up-regulation of glutathione reductase expression was quantified by qPCR. Results of the current work indicates that NTC possess a potent cancer cell abolishing activity by simultaneous induction of intrinsic and extrinsic pathways of apoptosis in colon cancer cell lines.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications